8 analysts have expressed a variety of opinions on HealthEquity (NASDAQ:HQY) over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a ...

The need to address disparities in cancer screening rates is an oft-discussed issue in healthcare. Strategies on how to address the issue are less straightforward, leaving many leaders searching for ...

Health equity is a primary concern at Metropolitan Hospital, which serves a diverse community in New York City. The new CMO of Metropolitan Hospital, which is part of NYC Health + Hospitals, is ...

The U.S. health system ranks last among 10 nations on key health equity, access to care and outcome measures, despite the fact it spends by far the most on healthcare, according to a study by the ...

AI-driven solutions by physician-led tech firms aim to streamline drug denial appeals, reducing provider workload and improving patient outcomes. CKD screening at age 55 with SGLT2 inhibitors is ...

Health equity—the concept that every person has a fair and just opportunity to attain their maximum level of health—has never rung more true in today's highly driven healthcare world. Yet despite ...

HealthEquity, Inc. HQY posted better-than-expected first-quarter results after Tuesday’s closing bell. HealthEquity reported quarterly earnings of 97 cents per share, which beat the consensus estimate ...

The Collaborative Care Model has expanded significantly but faces barriers like start-up costs and inconsistent reimbursement, limiting access despite proven mental health benefits. Racial disparities ...

Delaware has the highest percentage of facilities that scored perfectly on health equity measures, while New Hampshire has the lowest, according to CMS data. The Health Equity-State used hospital ...

For Valentine Golden Ghanem, health data is more than numbers; it is a reflection of who is included—and excluded—within ...

HealthEquity (NASDAQ:HQY) is gearing up to announce its quarterly earnings on Wednesday, 2025-12-03. Here's a quick overview of what investors should know before the release. Analysts are estimating ...